New control of the senescence barrier in breast cancer

Normal cells exposed to cancer-causing events respond by triggering cellular senescence, a stress response which halts cell proliferation and constitutes a protective anti-cancer barrier. We have uncovered a previously unknown signaling pathway implicating p21-activated kinase 4 (PAK4) in the contro...

Full description

Bibliographic Details
Main Authors: Tânia D. F. Costa, Staffan Strömblad
Format: Article
Language:English
Published: Taylor & Francis Group 2020-03-01
Series:Molecular & Cellular Oncology
Subjects:
Online Access:http://dx.doi.org/10.1080/23723556.2019.1684129
_version_ 1797677133877739520
author Tânia D. F. Costa
Staffan Strömblad
author_facet Tânia D. F. Costa
Staffan Strömblad
author_sort Tânia D. F. Costa
collection DOAJ
description Normal cells exposed to cancer-causing events respond by triggering cellular senescence, a stress response which halts cell proliferation and constitutes a protective anti-cancer barrier. We have uncovered a previously unknown signaling pathway implicating p21-activated kinase 4 (PAK4) in the control of senescence in breast cancer, via the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) subunit RELB and the CCAAT-enhancer-binding protein beta (C/EBPβ).
first_indexed 2024-03-11T22:40:32Z
format Article
id doaj.art-2882f433756f46b09af456ad355a1356
institution Directory Open Access Journal
issn 2372-3556
language English
last_indexed 2024-03-11T22:40:32Z
publishDate 2020-03-01
publisher Taylor & Francis Group
record_format Article
series Molecular & Cellular Oncology
spelling doaj.art-2882f433756f46b09af456ad355a13562023-09-22T09:11:01ZengTaylor & Francis GroupMolecular & Cellular Oncology2372-35562020-03-017210.1080/23723556.2019.16841291684129New control of the senescence barrier in breast cancerTânia D. F. Costa0Staffan Strömblad1Karolinska InstitutetKarolinska InstitutetNormal cells exposed to cancer-causing events respond by triggering cellular senescence, a stress response which halts cell proliferation and constitutes a protective anti-cancer barrier. We have uncovered a previously unknown signaling pathway implicating p21-activated kinase 4 (PAK4) in the control of senescence in breast cancer, via the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) subunit RELB and the CCAAT-enhancer-binding protein beta (C/EBPβ).http://dx.doi.org/10.1080/23723556.2019.1684129cellular senescencep21-activated kinasepak4relbcebpb
spellingShingle Tânia D. F. Costa
Staffan Strömblad
New control of the senescence barrier in breast cancer
Molecular & Cellular Oncology
cellular senescence
p21-activated kinase
pak4
relb
cebpb
title New control of the senescence barrier in breast cancer
title_full New control of the senescence barrier in breast cancer
title_fullStr New control of the senescence barrier in breast cancer
title_full_unstemmed New control of the senescence barrier in breast cancer
title_short New control of the senescence barrier in breast cancer
title_sort new control of the senescence barrier in breast cancer
topic cellular senescence
p21-activated kinase
pak4
relb
cebpb
url http://dx.doi.org/10.1080/23723556.2019.1684129
work_keys_str_mv AT taniadfcosta newcontrolofthesenescencebarrierinbreastcancer
AT staffanstromblad newcontrolofthesenescencebarrierinbreastcancer